
The U.S. government has reclassified FDA-approved and state-licensed medical marijuana from Schedule I, the most restrictive drug category, to Schedule III, which includes substances with lower abuse potential. This change, announced by Acting Attorney General Todd Blanche, does not legalize marijuana federally but eases research restrictions, reduces tax burdens, and may benefit cannabis companies. A hearing is scheduled for June to consider broader rescheduling, following President Trump's directive to expedite marijuana policy reform.
The article group presents a range of perspectives focusing on federal policy changes under the Trump administration, highlighting official statements and industry reactions. Coverage includes government rationale for reclassification, business impacts, and ongoing regulatory processes, reflecting both supportive views on medical access and research expansion and acknowledgment of marijuana's continued federal illegality. The framing is largely policy- and fact-oriented without partisan editorializing.
The overall tone across the articles is cautiously positive, emphasizing the policy shift as a significant step toward easing restrictions on medical marijuana. Coverage highlights benefits for research, patient access, and the cannabis industry, while maintaining a neutral stance on legalization. The sentiment balances optimism about regulatory progress with recognition of remaining legal limitations.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| mint | US reclassifies some Marijuana products as less dangerous; hearing set for June 2026 Today News | Center | Neutral |
| theprint | US to loosen marijuana rules in major shift for 47 billion industry | Center | Positive |
| hindustantimes | US eases cannabis for medical use: Access, research, and regulation explained | Center | Positive |
| economictimes | Has Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock Market | Center | Positive |
| news18 | Weed Gets Relief In America: Why US Just Took Its Biggest Cannabis Step Yet | Center | Neutral |
| theprint | US reclassifies certain marijuana products as a less-dangerous drug | Center | Positive |
theprint broke this story on 23 Apr, 01:07 pm. Other outlets followed.
Story is receiving appropriate media attention relative to public interest.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.